Your weight has moved and your body has reorganised, and neither of those things responds to what used to work. This is one of the most distressing parts of the transition and one of the most badly explained, largely because two separate processes get bundled together.
Separating them makes the whole thing more manageable, and considerably less personally damning.
Two different things are happening
Weight gain in midlife is mostly about age, not menopause. Women in their forties and fifties gain weight at a fairly steady rate — on the order of half a kilogram or so a year in longitudinal cohorts — and studies that compare women going through the transition with women of the same age who aren't have generally found that the amount of weight gained doesn't differ much. It's a midlife pattern, driven by declining muscle mass, reduced activity and the ordinary metabolic drift of ageing.
Body composition change is about menopause. This is where the transition has a distinct signature. Analyses tracking women through the transition have found that fat mass gain accelerates around the final menstrual period — in one detailed analysis, beginning roughly two years before and continuing about a year and a half after, then flattening — while lean mass declines over a similar window.
And the fat relocates. Visceral fat, the deep abdominal fat around organs, increases disproportionately. Women describe this precisely: same number on the scale, completely different shape, trousers that no longer fit at the waist.
Why it matters beyond appearance
Visceral fat is metabolically active in ways subcutaneous fat isn't. It's more strongly associated with insulin resistance, unfavourable cholesterol changes and cardiovascular risk.
This coincides with other shifts across the transition — in lipid profile and in vascular function — and cardiovascular disease is the leading cause of death in women. So the midlife body composition conversation is genuinely a cardiovascular conversation, not a cosmetic one. That's not a reason for alarm. It's a reason to treat the waist measurement as a health metric rather than a self-esteem metric.
Be the first to know when we launch.
We'll only email you about the launch. See our privacy policy.
Why the old approach stops working
Muscle is disappearing quietly. Muscle mass declines from around the third decade and the decline steepens in midlife. Muscle is metabolically expensive tissue. Less of it means a lower resting energy expenditure, so the same eating produces a different result.
Eating less makes it worse. The instinctive response — cut intake sharply — accelerates muscle loss, particularly without adequate protein and resistance training. Which lowers resting expenditure further. Which makes the next attempt harder. A substantial number of women arrive at 50 having done this repeatedly since 25.
Sleep and appetite are connected. Poor sleep alters the hormones regulating hunger and satiety, increases appetite, and shifts preference toward energy-dense food. If you're not sleeping, appetite regulation is working against you before any decision gets made.
What has actual support
Resistance training. The single highest-return intervention for midlife body composition. It preserves and can build muscle, supports bone density at the point bone loss accelerates, and improves insulin sensitivity. Two to three sessions a week, with load that's genuinely challenging. Light weights and high repetitions are not the same stimulus.
Protein. Requirements are higher for maintaining muscle in older adults than the general population guidance suggests, and most women in this age group fall well short. Spreading it across meals rather than loading it into dinner is better for muscle protein synthesis.
Not under-eating. Aggressive restriction costs muscle. Moderate deficit alongside resistance training preserves it.
Weight loss is on the recommended list for hot flushes. The Menopause Society's 2023 review found sufficient evidence to recommend weight loss as a non-hormonal approach to vasomotor symptoms in women with higher body weight — one of the few lifestyle interventions that made the list.
What hormone therapy does and doesn't do
Hormone therapy is not a weight loss treatment and shouldn't be started for that reason. Evidence on whether it modifies fat distribution is mixed, with some suggestion of a modest effect on abdominal fat accumulation but nothing that would justify it on that basis alone.
Indirectly, it can help — by improving sleep and reducing the exhaustion that makes exercise impossible. But the direct effect on the scale is not the reason to take it.
The reframe worth making
Weighing yourself is measuring the wrong thing during a period when muscle is falling and fat is rising. The scale can hold steady while the underlying composition deteriorates.
More useful: waist measurement, strength (are the weights going up), and how you function. Those track what actually matters here, and they respond to what you do, which the scale sometimes stubbornly refuses to.
Sources
- Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. - Lovejoy JC, Champagne CM, de Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008;32(6):949–958. - The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573–590. - Karvonen-Gutierrez C, Kim C. Association of mid-life changes in body size, body composition and obesity status with the menopausal transition. Healthcare. 2016;4(3):42. - El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention. Circulation. 2020;142(25):e506–e532.